Comparative Efficacy of Oral Traditional Chinese Patent Medicines for Acute Cerebral Infarction: A Protocol for a Systematic Review and Network Meta-Analysis
Traditional Chinese patent medicines (TCPMs) are widely used in the treatment of acute cerebral infarction (ACI) in China. Many oral traditional Chinese patent medicines have been reported to be effective for ACI. However, a comparison of randomized controlled trials (RCTs) to directly compare the efficacy of the different oral TCPMs has not been performed. There is no evidence to demonstrate which of oral TCPMs are more effective for clinicians. Therefore, we plan to conduct a systematic review and network meta-analysis (NMA) to compare the efficacy of 10 kinds of oral TCPMs for ACI. The aim is to provide the best currently available evidence base to guide the selection of oral TCPMs. Read more here.